New immunotherapy treatment helps bladder cancer patients avoid surgery and stay cancer-free
A recent clinical trial has found that adding a new immunotherapy drug called durvalumab to traditional chemotherapy and radiation therapy […]
Pharmaceutical News
New EU Rules to Better Assess Chemical Safety for Health and Environment
Starting January 1st, the European Union has introduced new laws to improve how chemicals are evaluated for safety. This is
Pharmaceutical News
Pfizer and Innovent Biologics Join Forces to Develop New Cancer Treatments Worth Up to $10.5 Billion
Leading pharmaceutical companies Pfizer and Innovent Biologics have signed a major agreement to work together on developing 12 new cancer
New Study Finds Bimekizumab More Effective Than Risankizumab for Psoriatic Arthritis
UCB, a pharmaceutical company, has shared new results from a major clinical trial called the BE BOLD study. The trial
New Hope for Patients with a Specific Type of Advanced Bowel Cancer: European Medicines Agency Recommends Approval of a Targeted Treatment Combination
Pierre Fabre Laboratories has received a positive recommendation from the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human
UK Health Watchdog Recommends GSK’s Nucala (mepolizumab) for New Use
Great news for patients with severe asthma! The UK’s health watchdog, the National Institute for Health and Care Excellence (NICE),
Pharmaceutical News
New Treatment Approved for Rare Blood Cancer, While Breast Cancer Drug Faces Delay
The U.S. Food and Drug Administration (FDA) has made two important decisions in cancer treatment this week. First, they approved
Pharmaceutical News
New Report Shows U.S. Brand-Name Drug Prices Rise Sharply While They Drop in Other Countries
A recent report from the AARP Public Policy Institute reveals that the prices of many top brand-name prescription drugs in
New Study Shows Pepaxti is Safe and Effective for Multiple Myeloma Patients with Kidney Problems
Oncopeptides, a pharmaceutical company, has shared new findings from a clinical trial that show the drug Pepaxti can be safely
Pharmaceutical News
Major Diabetes Drug Maker Sues Over Alleged $200 Million Fraud Scheme Involving Mail-Order Pharmacies and Church-Affiliated Groups
A large pharmaceutical company, Eli Lilly, has filed a lawsuit in Miami accusing several businesses and individuals of defrauding them